Application Sponsors
ANDA 090284 | INVAGEN PHARMS | |
Marketing Status
Application Products
001 | TABLET, EXTENDED RELEASE;ORAL | 10MG | 0 | ALFUZOSIN HYDROCHLORIDE | ALFUZOSIN HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 2012-01-17 | |
LABELING; Labeling | SUPPL | 4 | AP | 2015-01-13 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2015-01-13 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 15 |
SUPPL | 4 | Null | 7 |
SUPPL | 5 | Null | 7 |
TE Codes
CDER Filings
INVAGEN PHARMS
cder:Array
(
[0] => Array
(
[ApplNo] => 90284
[companyName] => INVAGEN PHARMS
[docInserts] => ["",""]
[products] => [{"drugName":"ALFUZOSIN HYDROCHLORIDE","activeIngredients":"ALFUZOSIN HYDROCHLORIDE","strength":"10MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"ALFUZOSIN HYDROCHLORIDE","submission":"ALFUZOSIN HYDROCHLORIDE","actionType":"10MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)